Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team

Executive Summary

Sienna Biopharmaceuticals went from Series A to IPO in 15 months, selling investors on its executive team experienced in the development and commercialization of dermatology and aesthetic products.

Advertisement

Related Content

Finance Watch: Anchiano, TCR2, Hoth And Stealth Make Seven US Biopharma IPOs For 2019
Finance Watch Public Company Edition: Akcea, Kala Launch IPOs While FOPOs Keep Busy Pace
Finance Watch: Cash Flows Into Public Biopharmas, Including IPOs; Atlas Raises $350m VC Fund
Finance Watch: OncoMed Cuts Costs To Conserve Capital While Public, Private Peers Raise Cash
Pfizer’s Eucrisa Approval By FDA Adds New Dermatology Anchor
Itch-Focused Creabilis Finally Secures Its Future Through US Sale
IPO Update: Novan, AC Immune End Summer Slowdown As Market Improves
VC Roundup: 2Q Financings Fall As Per-Company Averages Rise
Pfizer Buys Anacor With Blockbuster Ambitions For Crisaborole
Allergan buys chin fat firm Kythera for $2.1bn

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099253

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel